Yuefeng Yang

1.3k total citations
34 papers, 1.1k citations indexed

About

Yuefeng Yang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yuefeng Yang has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in Yuefeng Yang's work include Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers) and MicroRNA in disease regulation (7 papers). Yuefeng Yang is often cited by papers focused on Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers) and MicroRNA in disease regulation (7 papers). Yuefeng Yang collaborates with scholars based in China, United States and Netherlands. Yuefeng Yang's co-authors include Fengjun Xiao, Lisheng Wang, Hua Wang, Prem Seth, Linggang Wang, Zhengwei Fu, Cheng Zhou, Yuanxiang Jin, Yuxiang Li and Ye Wu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Chemosphere and International Journal of Molecular Sciences.

In The Last Decade

Yuefeng Yang

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuefeng Yang China 21 588 387 273 231 150 34 1.1k
Yao Dong China 20 568 1.0× 280 0.7× 231 0.8× 66 0.3× 62 0.4× 70 1.2k
Ying Cao United States 23 1.2k 2.0× 306 0.8× 402 1.5× 64 0.3× 169 1.1× 48 1.7k
Yongfang Wang China 19 610 1.0× 302 0.8× 296 1.1× 107 0.5× 131 0.9× 90 1.3k
Melanie Wurm Germany 9 820 1.4× 236 0.6× 213 0.8× 303 1.3× 31 0.2× 17 1.2k
Gabrielle S. Le Provost United States 18 1.2k 2.1× 812 2.1× 221 0.8× 378 1.6× 56 0.4× 22 1.7k
Shunqian Jin United States 23 1.2k 2.1× 246 0.6× 576 2.1× 203 0.9× 91 0.6× 42 1.8k
Songbo Xie China 26 1.1k 1.9× 131 0.3× 377 1.4× 141 0.6× 89 0.6× 67 1.6k
Kee-Ho Lee South Korea 20 855 1.5× 200 0.5× 246 0.9× 116 0.5× 97 0.6× 48 1.4k
Yu Pan China 25 1.1k 2.0× 407 1.1× 816 3.0× 77 0.3× 127 0.8× 89 1.9k
Carol J. Oborn United States 16 481 0.8× 123 0.3× 329 1.2× 178 0.8× 82 0.5× 19 981

Countries citing papers authored by Yuefeng Yang

Since Specialization
Citations

This map shows the geographic impact of Yuefeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuefeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuefeng Yang more than expected).

Fields of papers citing papers by Yuefeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuefeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuefeng Yang. The network helps show where Yuefeng Yang may publish in the future.

Co-authorship network of co-authors of Yuefeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuefeng Yang. A scholar is included among the top collaborators of Yuefeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuefeng Yang. Yuefeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vickman, Renee E., Yuefeng Yang, Zebin Hu, et al.. (2024). The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Therapy. 31(4). 574–585. 2 indexed citations
3.
Li, Yuxiang, Fengjun Xiao, Aimei Zhang, et al.. (2020). Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cellular Immunology. 348. 104041–104041. 69 indexed citations
4.
5.
Xiao, Fengjun, Dan Zhang, Ye Wu, et al.. (2019). miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochemical and Biophysical Research Communications. 515(3). 448–454. 141 indexed citations
7.
Wang, Hao, Weidong Xu, Tao Wang, et al.. (2018). Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model. Human Gene Therapy. 30(2). 197–210. 22 indexed citations
8.
Yang, Wenzhuo, Yanning Yang, Lu Xia, et al.. (2016). MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt. Cellular Physiology and Biochemistry. 38(6). 2366–2374. 33 indexed citations
9.
Wang, Hua, Qinqin Xu, Fengjun Xiao, et al.. (2016). Exosomal miR-486 regulates hypoxia-induced erythroid differentiation of erythroleukemia cells through targeting Sirt1. Experimental Cell Research. 351(1). 74–81. 29 indexed citations
10.
Zhu, Li, Fengjun Xiao, Yue Yu, et al.. (2016). KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL. Anti-Cancer Drugs. 27(9). 863–872. 20 indexed citations
11.
Zhao, Yingying, Yuqiong Wang, Yuefeng Yang, et al.. (2015). MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting. Journal of Cancer. 6(12). 1230–1235. 19 indexed citations
12.
Wang, Lifeng, Dawei Tian, Haijuan Li, et al.. (2015). Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment. Molecular Neurobiology. 53(4). 2100–2111. 7 indexed citations
13.
Yin, Yue, Huiyan Sun, Jun Xu, et al.. (2014). Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells. Leukemia & lymphoma. 56(6). 1813–1820. 16 indexed citations
14.
Zhao, Li, Yuefeng Yang, Yabing Gao, et al.. (2014). Upregulation of HIF-1α Via Activation of ERK and PI3K Pathway Mediated Protective Response to Microwave-Induced Mitochondrial Injury in Neuron-Like Cells. Molecular Neurobiology. 50(3). 1024–1034. 27 indexed citations
15.
Zhao, Li, Chengfeng Sun, Lu Xiong, et al.. (2014). MicroRNAs: Novel Mechanism Involved in the Pathogenesis of Microwave Exposure on Rats’ Hippocampus. Journal of Molecular Neuroscience. 53(2). 222–230. 18 indexed citations
16.
Liu, Xiaoyun, Yuefeng Yang, Fengjun Xiao, et al.. (2011). Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism. Biochemical and Biophysical Research Communications. 410(4). 803–808. 21 indexed citations
17.
Wang, Hua, Yun Leng, Zeliang Li, et al.. (2011). Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. Biochemical and Biophysical Research Communications. 414(1). 233–239. 91 indexed citations
18.
Jin, Yuanxiang, Linggang Wang, Jingwen Liu, et al.. (2011). Cypermethrin exposure during puberty induces oxidative stress and endocrine disruption in male mice. Chemosphere. 84(1). 124–130. 75 indexed citations
19.
Jin, Yuanxiang, Rujia Chen, Linggang Wang, et al.. (2010). Effects of metolachlor on transcription of thyroid system-related genes in juvenile and adult Japanese medaka (Oryzias latipes). General and Comparative Endocrinology. 170(3). 487–493. 29 indexed citations
20.
Xiao, Fengjun, Jun Yan, Yuefeng Yang, et al.. (2009). Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein. Biochemical and Biophysical Research Communications. 386(1). 35–39. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026